Sagamihara, Japan

Yoshio Ito


Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1990-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Yoshio Ito

Introduction

Yoshio Ito is a prominent inventor based in Sagamihara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have valuable applications in medicine. With a total of 2 patents to his name, his work continues to impact the industry.

Latest Patents

Yoshio Ito's latest patents include innovative compounds that are crucial in the synthesis of antibiotics. One of his notable patents is for heterocyclic compounds and their production. This patent describes a compound of the formula: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, and R.sub.4 can be various groups, including hydrogen atoms and alkyl groups. This compound serves as an intermediate in the synthesis of 1.beta.-methylcarbapenem compounds, which are valuable as antibiotics. Another significant patent involves amino acid derivatives and their production. This patent outlines an amino acid derivative of the formula: ##STR1## where R.sup.1 is a protective group for hydroxyl, which is useful as an intermediate for the production of antimicrobial agents.

Career Highlights

Yoshio Ito is currently associated with Sumitomo Pharmaceuticals Company Limited, where he continues to innovate and develop new pharmaceutical compounds. His work has been instrumental in advancing the field of medicinal chemistry.

Collaborations

Yoshio has collaborated with notable colleagues such as Shiro Terashima and Kunikazu Sakai, contributing to various projects that enhance the pharmaceutical landscape.

Conclusion

Yoshio Ito's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in antibiotic development and antimicrobial agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…